Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer
/PRNewswire/ -- Q BioMed, Inc. (OTCQB: QBIO) a commercial-stage biotechnology development company announces a new publication supporting the potential superior...
United States South Korea Ruby John Anto Denis Corin Keith Pinder Rajiv Gandhi Centre For Biotechnology
Source: prnewswire.com